Literature DB >> 9243033

Can we agree on the treatment of candidiasis?

J R Graybill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9243033     DOI： 10.1086/514503

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  In vitro interaction between fluconazole and triclosan against clinical isolates of fluconazole-resistant Candida albicans determined by different methods.

Authors:  Lu Yu; Guanghui Ling; Xuming Deng; Jing Jin; Qi Jin; Na Guo
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

2.  Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.

Authors:  O Marchetti; P Moreillon; M P Glauser; J Bille; D Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 3.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

4.  In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods.

Authors:  Shujuan Sun; Yan Li; Qiongjie Guo; Changwen Shi; Jinlong Yu; Lin Ma
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.